gb115 peptide GB 115 - GB-115 effects Peptides GB115 Peptide: A Novel Anxiolytic with Diverse Applications

GB-115 mechanism of action GB115 peptide, chemically known as N-(6-phenylhexanoyl)glycyl-L-tryptophan amide, is a synthetic dipeptide that has garnered significant attention for its potent anxiolytic properties. Developed using a strategy that moves from endogenous peptides to drug design, GB115 represents a novel approach to treating anxiety disorders. Its unique mechanism of action, targeting central cholecystokinin-1 receptors, distinguishes it from traditional anxiolytics and suggests a potentially favorable safety profile with fewer side effectsGB-115 | CAS 678996-63-9. This article delves into the scientific exploration of GB115 peptide, encompassing its chemical structure, pharmacological effects, and emerging applications.Impact of central antagonist of cholecystokinin-1 receptors ...

Understanding the Mechanism of Action

The efficacy of GB115 peptide in alleviating anxiety stems from its role as a central antagonist of cholecystokinin-1 receptors. Cholecystokinin (CCK) is a neuropeptide that plays a role in various physiological processes, including digestion and satiety, but also in the modulation of anxiety and fear responses. By blocking the action of CCK at its specific receptors in the central nervous system, GB115 can exert anxiolytic effects. This targeted approach is crucial for its therapeutic potential, aiming to reduce anxiety without the broad, often sedating, effects associated with other classes of anxiolytics. Research indicates that GB-115 exhibits anxiolytic action with mild psychostimulant properties, suggesting a balanced effect that may be beneficial for patients experiencing both anxiety and fatigue作者：O Dorofeeva·2022—GB-115action in the treatment of GAD patients is characterized with anxiolytic action with mild psychostimulant properties..

Preclinical and Clinical Investigations

Extensive research has been conducted to elucidate the pharmacokinetic and pharmacodynamic properties of GB115 peptide. Studies have evaluated its behavior within biological systems, including its absorption, distribution, metabolism, and excretion. For instance, pharmacokinetic studies have been performed in various animal models, such as rats and rabbits, and have extended to human volunteers, providing crucial data for understanding its clinical use. A chromatographic method for quantitative determination of the peptide GB-115 in biological media using HPLC/MS has been developed, enabling precise measurement of the compound in research settings.

The therapeutic potential of GB115 is being explored in several key areas:

* Anxiety Disorders: The primary focus of GB115 peptide research is its application in treating generalized anxiety disorder (GAD) and other anxiety-related conditions. Clinical trials, such as the study referenced by NCT05586789, are investigating the efficacy and safety of Ranquilon (the brand name for GB-115 in Russia) in patients with anxiety. Early findings suggest a clinically significant anxiolytic effect.

* Anti-inflammatory Effects: Beyond its anxiolytic properties, studies have also highlighted the anti-inflammatory effects of GB-115. Research by Shipaeva and colleagues in 2011 demonstrated that intraperitoneal injections of GB-115 in doses of 0.1, 1, and 10 mg/kg exhibited anti-inflammatory activity.作者：EV Shipaeva·2011·被引用次数：1—Anti-inflammatory effects ofGB-115compound (N-phenylhexanoyl-glycyl-L-tryptophan amide) injected intraperitoneally in doses of 0.1, 1, and 10 mg/kg were ... Specifically, in a model of experimental autoimmune encephalomyelitis in mice, a dose of 1 mg/kg significantly alleviated the disease. This suggests potential applications in conditions with an inflammatory component.

* Cognitive Processes: The impact of GB115 peptide on cognitive functions in patients with GAD is also under investigationNovel Technologies for Dipeptide Drugs Design and their .... Understanding how this peptide influences cognitive processes alongside its anxiolytic effects is vital for a comprehensive therapeutic profile.

* Fatigue Reduction: Intriguingly, GB-115 has also been identified as a peptide that powerfully reduces fatigue. This dual action of reducing anxiety and combating fatigue could offer a significant advantage for individuals suffering from debilitating symptoms.

Chemical Structure and Properties

The chemical structure of GB115 peptide is N-(6-phenylhexanoyl)glycyl-L-tryptophan amide.GB-115 [CAS: 678996-63-9] glixxlabs.com High quality ... This specific arrangement of amino acids and the phenylhexanoyl group contributes to its selective binding to CCK receptors and its overall pharmacological profile. The physicochemical properties of GB-115 have been studied to ensure its stability and suitability for pharmaceutical development. While it is a peptide, its relatively smaller size compared to larger peptide therapeutics allows for specific receptor targeting.

Availability and Future Directions

GB115 peptide has been approved in Russia under the brand name Ranquilon. Research continues to explore its full therapeutic spectrum.Effect of the dipeptide retro-analog of cholecystokinin ... The development of GB-115 as a selective dipeptide anxiolytic highlights the ongoing innovation in peptide-based drug design.作者：O Dorofeeva·2022—Introduction: The pilot clinical study ofGB-115, a newpeptideantagonist of central cholecystokinin-1 receptors, revealed that drug was clinically ... Future research may focus on optimizing delivery methods, expanding clinical trials to a broader patient population, and further investigating its potential in other neurological and inflammatory conditions. The availability of GB 115 as a spray solution (e.g.GB-115 [CAS: 678996-63-9] glixxlabs.com High quality ..., 2mg/mL) and in capsule form (e.g., 2.5 mg/capsule) indicates progress in its formulation for potential therapeutic use....PeptideVials ·PeptideCapsules ·PeptideTablets ·PeptideNano Liposomals ...GB115-60CAPS Categories: New Releases Category, Nootropic Capsule, Research ...

In conclusion, GB115 peptide represents a promising advancement in the field of psychopharmacology. Its targeted mechanism of action, coupled with emerging evidence of anti-inflammatory and fatigue-reducing properties, positions it as a molecule with significant therapeutic potential for a range of health concerns. Continued scientific inquiry will undoubtedly further define the role of this innovative peptide in medicine.